Abstract
Summary
A cough is a sudden, and often repetitively occurring, protective reflex which helps to clear the large breathing passages from fluids, irritants, foreign particles and microbes. Children Cough Medicine helps control your child’s cough plus thins and loosens mucus to relieve chest congestion so your child can get back to normal.
The global Children Cough Medicine market size is projected to grow from US$ 1543 million in 2024 to US$ 2587 million in 2030; it is expected to grow at a CAGR of 9.0% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Children Cough Medicine Industry Forecast” looks at past sales and reviews total world Children Cough Medicine sales in 2023, providing a comprehensive analysis by region and market sector of projected Children Cough Medicine sales for 2024 through 2030. With Children Cough Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Children Cough Medicine industry.
This Insight Report provides a comprehensive analysis of the global Children Cough Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Children Cough Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Children Cough Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Children Cough Medicine and breaks down the forecast by Type, by Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Children Cough Medicine.
Global key players of Children Cough Medicine include Johnson & Johnson, Reckitt Benckiser, Sunflower Pharmaceutical Group, Hainan Huluwa, Pharmaceutical Group, China Resources Sanjiu Medical & Pharmaceutical, STADA, Sanofi, Jumpcan Pharmaceutical, Hyland's, Foundation Consumer Healthcare (Dimetapp) etc. The top five players hold a share over 47%. APAC is the largest market, and has a share about 54%, followed by Americas and Europe with share 23% and 20%, separately. In terms of product type, OTC Medicines is the largest segment, occupied for a share of 88%. In terms of channel, Drug Stores has a share about 72 percent.
This report presents a comprehensive overview, market shares, and growth opportunities of Children Cough Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
OTC Medicines
Prescription Medicines
Segmentation by Channel:
Hospitals
Drug Stores
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Reckitt Benckiser
Sunflower Pharmaceutical Group
Hainan Huluwa Pharmaceutical Group
China Resources Sanjiu Medical & Pharmaceutical
STADA
Sanofi
Jumpcan Pharmaceutical
Hyland's
Foundation Consumer Healthcare (Dimetapp)
Key Questions Addressed in this Report
What is the 10-year outlook for the global Children Cough Medicine market?
What factors are driving Children Cough Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Children Cough Medicine market opportunities vary by end market size?
How does Children Cough Medicine break out by Type, by Channel?
The global Children Cough Medicine market size is projected to grow from US$ 1543 million in 2024 to US$ 2587 million in 2030; it is expected to grow at a CAGR of 9.0% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Children Cough Medicine Industry Forecast” looks at past sales and reviews total world Children Cough Medicine sales in 2023, providing a comprehensive analysis by region and market sector of projected Children Cough Medicine sales for 2024 through 2030. With Children Cough Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Children Cough Medicine industry.
This Insight Report provides a comprehensive analysis of the global Children Cough Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Children Cough Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Children Cough Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Children Cough Medicine and breaks down the forecast by Type, by Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Children Cough Medicine.
Global key players of Children Cough Medicine include Johnson & Johnson, Reckitt Benckiser, Sunflower Pharmaceutical Group, Hainan Huluwa, Pharmaceutical Group, China Resources Sanjiu Medical & Pharmaceutical, STADA, Sanofi, Jumpcan Pharmaceutical, Hyland's, Foundation Consumer Healthcare (Dimetapp) etc. The top five players hold a share over 47%. APAC is the largest market, and has a share about 54%, followed by Americas and Europe with share 23% and 20%, separately. In terms of product type, OTC Medicines is the largest segment, occupied for a share of 88%. In terms of channel, Drug Stores has a share about 72 percent.
This report presents a comprehensive overview, market shares, and growth opportunities of Children Cough Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
OTC Medicines
Prescription Medicines
Segmentation by Channel:
Hospitals
Drug Stores
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Reckitt Benckiser
Sunflower Pharmaceutical Group
Hainan Huluwa Pharmaceutical Group
China Resources Sanjiu Medical & Pharmaceutical
STADA
Sanofi
Jumpcan Pharmaceutical
Hyland's
Foundation Consumer Healthcare (Dimetapp)
Key Questions Addressed in this Report
What is the 10-year outlook for the global Children Cough Medicine market?
What factors are driving Children Cough Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Children Cough Medicine market opportunities vary by end market size?
How does Children Cough Medicine break out by Type, by Channel?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Children Cough Medicine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Children Cough Medicine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Children Cough Medicine by Country/Region, 2019, 2023 & 2030
2.2 Children Cough Medicine Segment by Type
2.2.1 OTC Medicines
2.2.2 Prescription Medicines
2.3 Children Cough Medicine Sales by Type
2.3.1 Global Children Cough Medicine Sales Market Share by Type (2019-2024)
2.3.2 Global Children Cough Medicine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Children Cough Medicine Sale Price by Type (2019-2024)
2.4 Children Cough Medicine Segment by Channel
2.4.1 Hospitals
2.4.2 Drug Stores
2.5 Children Cough Medicine Sales by Channel
2.5.1 Global Children Cough Medicine Sale Market Share by Channel (2019-2024)
2.5.2 Global Children Cough Medicine Revenue and Market Share by Channel (2019-2024)
2.5.3 Global Children Cough Medicine Sale Price by Channel (2019-2024)
3 Global by Company
3.1 Global Children Cough Medicine Breakdown Data by Company
3.1.1 Global Children Cough Medicine Annual Sales by Company (2019-2024)
3.1.2 Global Children Cough Medicine Sales Market Share by Company (2019-2024)
3.2 Global Children Cough Medicine Annual Revenue by Company (2019-2024)
3.2.1 Global Children Cough Medicine Revenue by Company (2019-2024)
3.2.2 Global Children Cough Medicine Revenue Market Share by Company (2019-2024)
3.3 Global Children Cough Medicine Sale Price by Company
3.4 Key Manufacturers Children Cough Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Children Cough Medicine Product Location Distribution
3.4.2 Players Children Cough Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Children Cough Medicine by Geographic Region
4.1 World Historic Children Cough Medicine Market Size by Geographic Region (2019-2024)
4.1.1 Global Children Cough Medicine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Children Cough Medicine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Children Cough Medicine Market Size by Country/Region (2019-2024)
4.2.1 Global Children Cough Medicine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Children Cough Medicine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Children Cough Medicine Sales Growth
4.4 APAC Children Cough Medicine Sales Growth
4.5 Europe Children Cough Medicine Sales Growth
4.6 Middle East & Africa Children Cough Medicine Sales Growth
5 Americas
5.1 Americas Children Cough Medicine Sales by Country
5.1.1 Americas Children Cough Medicine Sales by Country (2019-2024)
5.1.2 Americas Children Cough Medicine Revenue by Country (2019-2024)
5.2 Americas Children Cough Medicine Sales by Type (2019-2024)
5.3 Americas Children Cough Medicine Sales by Channel (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Children Cough Medicine Sales by Region
6.1.1 APAC Children Cough Medicine Sales by Region (2019-2024)
6.1.2 APAC Children Cough Medicine Revenue by Region (2019-2024)
6.2 APAC Children Cough Medicine Sales by Type (2019-2024)
6.3 APAC Children Cough Medicine Sales by Channel (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Children Cough Medicine by Country
7.1.1 Europe Children Cough Medicine Sales by Country (2019-2024)
7.1.2 Europe Children Cough Medicine Revenue by Country (2019-2024)
7.2 Europe Children Cough Medicine Sales by Type (2019-2024)
7.3 Europe Children Cough Medicine Sales by Channel (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Children Cough Medicine by Country
8.1.1 Middle East & Africa Children Cough Medicine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Children Cough Medicine Revenue by Country (2019-2024)
8.2 Middle East & Africa Children Cough Medicine Sales by Type (2019-2024)
8.3 Middle East & Africa Children Cough Medicine Sales by Channel (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Children Cough Medicine
10.3 Manufacturing Process Analysis of Children Cough Medicine
10.4 Industry Chain Structure of Children Cough Medicine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Children Cough Medicine Distributors
11.3 Children Cough Medicine Customer
12 World Forecast Review for Children Cough Medicine by Geographic Region
12.1 Global Children Cough Medicine Market Size Forecast by Region
12.1.1 Global Children Cough Medicine Forecast by Region (2025-2030)
12.1.2 Global Children Cough Medicine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Children Cough Medicine Forecast by Type (2025-2030)
12.7 Global Children Cough Medicine Forecast by Channel (2025-2030)
13 Key Players Analysis
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Children Cough Medicine Product Portfolios and Specifications
13.1.3 Johnson & Johnson Children Cough Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Reckitt Benckiser
13.2.1 Reckitt Benckiser Company Information
13.2.2 Reckitt Benckiser Children Cough Medicine Product Portfolios and Specifications
13.2.3 Reckitt Benckiser Children Cough Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Reckitt Benckiser Main Business Overview
13.2.5 Reckitt Benckiser Latest Developments
13.3 Sunflower Pharmaceutical Group
13.3.1 Sunflower Pharmaceutical Group Company Information
13.3.2 Sunflower Pharmaceutical Group Children Cough Medicine Product Portfolios and Specifications
13.3.3 Sunflower Pharmaceutical Group Children Cough Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sunflower Pharmaceutical Group Main Business Overview
13.3.5 Sunflower Pharmaceutical Group Latest Developments
13.4 Hainan Huluwa Pharmaceutical Group
13.4.1 Hainan Huluwa Pharmaceutical Group Company Information
13.4.2 Hainan Huluwa Pharmaceutical Group Children Cough Medicine Product Portfolios and Specifications
13.4.3 Hainan Huluwa Pharmaceutical Group Children Cough Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Hainan Huluwa Pharmaceutical Group Main Business Overview
13.4.5 Hainan Huluwa Pharmaceutical Group Latest Developments
13.5 China Resources Sanjiu Medical & Pharmaceutical
13.5.1 China Resources Sanjiu Medical & Pharmaceutical Company Information
13.5.2 China Resources Sanjiu Medical & Pharmaceutical Children Cough Medicine Product Portfolios and Specifications
13.5.3 China Resources Sanjiu Medical & Pharmaceutical Children Cough Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 China Resources Sanjiu Medical & Pharmaceutical Main Business Overview
13.5.5 China Resources Sanjiu Medical & Pharmaceutical Latest Developments
13.6 STADA
13.6.1 STADA Company Information
13.6.2 STADA Children Cough Medicine Product Portfolios and Specifications
13.6.3 STADA Children Cough Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 STADA Main Business Overview
13.6.5 STADA Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Children Cough Medicine Product Portfolios and Specifications
13.7.3 Sanofi Children Cough Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Jumpcan Pharmaceutical
13.8.1 Jumpcan Pharmaceutical Company Information
13.8.2 Jumpcan Pharmaceutical Children Cough Medicine Product Portfolios and Specifications
13.8.3 Jumpcan Pharmaceutical Children Cough Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Jumpcan Pharmaceutical Main Business Overview
13.8.5 Jumpcan Pharmaceutical Latest Developments
13.9 Hyland's
13.9.1 Hyland's Company Information
13.9.2 Hyland's Children Cough Medicine Product Portfolios and Specifications
13.9.3 Hyland's Children Cough Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Hyland's Main Business Overview
13.9.5 Hyland's Latest Developments
13.10 Foundation Consumer Healthcare (Dimetapp)
13.10.1 Foundation Consumer Healthcare (Dimetapp) Company Information
13.10.2 Foundation Consumer Healthcare (Dimetapp) Children Cough Medicine Product Portfolios and Specifications
13.10.3 Foundation Consumer Healthcare (Dimetapp) Children Cough Medicine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Foundation Consumer Healthcare (Dimetapp) Main Business Overview
13.10.5 Foundation Consumer Healthcare (Dimetapp) Latest Developments
14 Research Findings and Conclusion